Danas gojaznost predstavlja globalni epidemiološki problem koji tokom vremena postoji sve veći. Međutim, efekti gojaznosti na respiratorni sistem često su neuvaženi. U ovom članku biće sagledani mehanički efekti gojaznosti na fiziologiju pluća kao i funkcija masnog tkiva kao endokrinog organa na produkciju sistemske inflamacije i uloge na centralnu kontrolu disanja. Gojaznost igra ključnu ulogu u razvoju opstruktivne apnee u spavanju i opstruktivnog hipoventilacionog sindroma. Bolje razumevanje efekata gojaznosti na respiratorne bolesti i pružanje adekvatnih mera zdravstvene zaštite je od vitalnog značaja u sprečavanju ovog sve značajnijeg problema.

Pulmonary embolism (PE) and venous thromboembolism are two clinical manifestations of a single entity - venous thromboembolism. PE usually occurs through due thrombi from the lower veins, and in 10-15% of cases are due thrombus from upper veins or right heart failure. Significance is mainly determined by the frequency (1/1000 per year in the adult population; less in younger but significant increase with increasing age), the risk of mortality is important in acute and chronic diseases that are associated with this clinical manifestation. Acute pulmonary embolism is often fatal, with a mean annual mortality of about 30% in untreated. Many deaths occur because of recurrent PE within the first few hours after the initial event. In the nineteenth century, Virchow the mechanism of thromboembolism categorized into three groups: changes in the blood vessel wall, a reduction of blood flow (path) and changes in the composition of the blood (hypercoagulable, prothrombotic). Modern interpretation of the pathogenesis of thromboembolism, which is processed corresponds Virhovljevom concept. In general thromboembolic events can be a result of complications of individual risk factors as increased thrombotic potential.

Koštani markeri su veoma korisno dijagnostiško sredstvo, mada je njihova klinička upotreba ograničena specifičnim tehničkim i analitičkim aspektima, kao i njihovom pre-analitičkom varijabilnošću. Koštani markeri, za razliku od mineralne gustine kosti, ukazuju na posebne aspekte kvaliteta kostiju, te stoga nude zasebnu i prognostičku perspektivu u ispitivanju promena mineralne gustine kosti I smanjivanju rizika od fraktura. Smanjenje nivoa koštanih markera usko je povezano sa smanjenjem rizika od frakture vratnih pršljenova usled korišćenja raloksifena, rizedronata i alendronata. Postoje brojne mogućnosti za korišćenje ovih markera u kratkoročnom praćenju toka lečenja osteoporoze, pored merenja mineralne koštane gustine, kako bi se otkrili pacijenti koji ne reaguju na terapiju.

Koštani markeri su veoma korisno dijagnostiško sredstvo, mada je njihova klinička upotreba ograničena specifičnim tehničkim i analitičkim aspektima, kao i njihovom pre-analitičkom varijabilnošću. Koštani markeri, za razliku od mineralne gustine kosti, ukazuju na posebne aspekte kvaliteta kostiju, te stoga nude zasebnu i prognostičku perspektivu u ispitivanju promena mineralne gustine kosti I smanjivanju rizika od fraktura. Smanjenje nivoa koštanih markera usko je povezano sa smanjenjem rizika od frakture vratnih pršljenova usled korišćenja raloksifena, rizedronata i alendronata. Postoje brojne mogućnosti za korišćenje ovih markera u kratkoročnom praćenju toka lečenja osteoporoze, pored merenja mineralne koštane gustine, kako bi se otkrili pacijenti koji ne reaguju na terapiju.

Leptin was discovered in 1994, finding, that marked the beginning of a new understanding about white adipose tissue. Up to end of 20th century this tissue was viewed as an inert tissue, devoted to body protection from heat loss and to passively store energy. This static vision, changed with identification of the product of the gene obese (ob) wich accentuated the role of adipose tissue in the physiopathology of obesity-linked diseases, and led to the discovery of various adipokines, many of a pro-inflammatory nature. With emerged knowledge of (WAT)-derived adipokines, it is obvious that they can be now considered as the bond between obesity-related environmental causes, such as nutrition and lifestyle, and the biochemical shifts that lead to metabolic syndrome, inflammatory and/or autoimmune conditions, and rheumatic diseases. This paper deals with reviews of recent adipokine research, with particular emphasis to the role of leptin, adiponectin, resistin, and visfatin in chondrocyte function and skeleton, as well as in inflammatory and degenerative cartilage joint diseases.